112
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Thermal ablation assisted laparoscopic partial nephrectomy for clinical T1b renal tumors

, , , , , & show all
Pages 179-184 | Received 08 Oct 2019, Accepted 18 May 2020, Published online: 20 Jul 2020

References

  • Escudier B, Porta C, Schmidinger M, et al. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2016;27(suppl 5):v58–v68.
  • Wang M, Mu X, Yang F, et al. Self-retaining barbed suture reduces warm ischemia time during laparoscopic partial nephrectomy. Minim Invasive Ther Allied Technol. 2018;27(5):272–277.
  • Ljungberg B, Bensalah K, Canfield S, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5):913–924.
  • Ng AM, Shah PH, Kavoussi LR. Laparoscopic partial nephrectomy: a narrative review and comparison with open and robotic partial nephrectomy. J Endourol. 2017;31(10):976–984.
  • Rimar K, Khambati A, McGuire BB, et al. Radiofrequency ablation-assisted zero-ischemia robotic laparoscopic partial nephrectomy: oncologic and functional outcomes in 49 patients. Adv Urol. 2016(2016):8045210.
  • Lin Y, Liang P, Yu XL, et al. Percutaneous microwave ablation of renal cell carcinoma is safe in patients with a solitary kidney. Urology. 2014;83(2):357–363.
  • Huang J, Zhang J, Wang Y, et al. Comparing zero ischemia laparoscopic radiofrequency ablation assisted tumor enucleation and laparoscopic partial nephrectomy for clinical T1a renal tumor: a randomized clinical trial. J Urol. 2016;195(6):1677–1683.
  • Jacomides L, Ogan K, Watumull L, et al. Laparoscopic application of radio frequency energy enables in situ renal tumor ablation and partial nephrectomy. J Urol. 2003;169(1):49–53.
  • Muto G, Castelli E, Migliari R, et al. Laparoscopic microwave ablation and enucleation of small renal masses: preliminary experience. Eur Urol. 2011;60(1):173–176.
  • Kutikov A, Uzzo RG. The R.E.N.A.L. nephrometry score: a comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009;182(3):844–853.
  • Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6(7):655–663.
  • Clavien PA, Sanabria JR, Strasberg SM. Proposed classification of complications of surgery with examples of utility in cholecystectomy. Surgery. 1992;111(5):518–526.
  • Levey AS, Coresh J, Greene T, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247–254.
  • Kunath F, Schmidt S, Krabbe LM, et al. Partial nephrectomy versus radical nephrectomy for clinical localised renal masses. Cochrane Database Syst Rev. 2017;5:CD012045
  • Singla N, Gahan J. New technologies in tumor ablation. Curr Opin Urol. 2016;26(3):248–253.
  • Zeltser IS, Moonat S, Park S, et al. Intermediate-term prospective results of radiofrequency-assisted laparoscopic partial nephrectomy: a non-ischaemic coagulative technique. BJU Int. 2008;101(1):36–38.
  • Zhao X, Zhang S, Liu G, et al. Zero ischemia laparoscopic radio frequency ablation assisted enucleation of renal cell carcinoma: experience with 42 patients. J Urol. 2012;188(4):1095–1101.
  • Choi SH, Kim JW, Kim JH, et al. Efficacy and safety of microwave ablation for malignant renal tumors: an updated systematic review and meta-analysis of the literature since 2012. Korean J Radiol. 2018;19(5):938–949.
  • Zhang C, Zhao X, Guo S, et al. Perioperative outcomes of zero ischemia radiofrequency ablation-assisted tumor enucleation for renal cell carcinoma: results of 182 patients. BMC Urol. 2018;18(1):41.
  • Uhlig J, Strauss A, Rücker G, et al. Partial nephrectomy versus ablative techniques for small renal masses: a systematic review and network meta-analysis. Eur Radiol. 2019;29(3):1293–1307.
  • Wu X, Chen W, Huang J, et al. Zero ischemia laparoscopic microwave ablation assisted enucleation vs. laparoscopic partial nephrectomy in clinical T1a renal tumor: a randomized clinical trial. Transl Cancer Res Tcr. 2020;9(1):194–202.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.